Tenaya Therapeutics (TNYA) Equity Ratio (2020 - 2026)

Tenaya Therapeutics has reported Equity Ratio for 7 years, with the latest figure at 0.79 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 5.21% year-over-year to 0.79; the trailing twelve-month figure through Mar 2026 stood at 0.79 (down 5.21% YoY), and the FY2025 full-year result was 0.84, up 8.37% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.79, down from 0.84 in the prior quarter.
• The five-year high for Equity Ratio was 0.88 in Q1 2022, with the low at 0.77 in Q4 2024.
• Average Equity Ratio over 5 years is 0.84, with a median of 0.84 recorded in 2025.
• Year-over-year, Equity Ratio soared 226.45% in 2022 and declined 6.28% in 2023.
• Tracing TNYA's Equity Ratio over 5 years: stood at 0.87 in 2022, then slipped by 6.28% to 0.82 in 2023, then slipped by 5.32% to 0.77 in 2024, then gained by 8.37% to 0.84 in 2025, then decreased by 6.29% to 0.79 in 2026.
• The last three Equity Ratio figures came in at 0.79 (Q1 2026), 0.84 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.

Peer Comparison